Adial Pharmaceuticals, Inc. (ADIL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1180 Seminole Trail
Charlottesville, VA 22901
United States of America (the)
Phone
434 422 9800
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
July 27, 2018
| Name | Title | Pay | Year Born |
| Cary John Claiborne | Chief Executive Officer, President & Director | 810,115 | 1961 |
| Tony Goodman | Chief Operating Officer & Director | 415,108 | 1964 |
| Vinay Shah | Chief Financial Officer & Treasurer | 453,603 | 1963 |
| John R. Martin | Chief Legal Officer | 0 | N/A |
| Brigitte Robertson | Acting Chief Medical Officer | 0 | 1964 |
| Abel Svitavsky | Controller | 0 | N/A |
| Andrew Taubman | Vice President of Corporate Development | 0 | N/A |
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.